The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.56 million shares were traded. INMB stock price reached its highest trading level at $1.65 during the session, while it also had its lowest trading level at $1.53.
Ratios:
We take a closer look at INMB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.17 and its Current Ratio is at 4.17. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $23.Rodman & Renshaw initiated its Buy rating on January 28, 2025, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 43333972 and an Enterprise Value of 16679971. For the stock, the TTM Price-to-Sale (P/S) ratio is 866.60 while its Price-to-Book (P/B) ratio in mrq is 1.71. Its current Enterprise Value per Revenue stands at 333.599.
Stock Price History:
The Beta on a monthly basis for INMB is 0.93, which has changed by -0.7340946 over the last 52 weeks, in comparison to a change of 0.12121439 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $11.64, while it has fallen to a 52-week low of $1.62. The 50-Day Moving Average of the stock is -14.63%, while the 200-Day Moving Average is calculated to be -68.78%.
Shares Statistics:
According to the various share statistics, INMB traded on average about 584.65K shares per day over the past 3-months and 341020 shares per day over the past 10 days. A total of 26.59M shares are outstanding, with a floating share count of 21.11M. Insiders hold about 20.61% of the company’s shares, while institutions hold 21.35% stake in the company. Shares short for INMB as of 1760486400 were 3476629 with a Short Ratio of 5.95, compared to 1757894400 on 3325709. Therefore, it implies a Short% of Shares Outstanding of 3476629 and a Short% of Float of 17.11.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 3.0 analysts currently analyzing and rating the stock of INmune Bio Inc (INMB).The consensus estimate for the next quarter is -$0.29, with high estimates of -$0.19 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.22 and -$1.59 for the fiscal current year, implying an average EPS of -$1.39. EPS for the following year is -$1.07, with 4.0 analysts recommending between -$0.72 and -$1.3.
